FDA labels
Search the openFDA drug-label export by label identifier, NDC, application, RxCUI, UNII, product name, or manufacturer.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report.
Label matches#
| Label | Generic name | Manufacturer | SPL set ID | Effective date | Safety fields | Match |
|---|---|---|---|---|---|---|
| SPRYCEL | DASATINIB | E.R. Squibb & Sons, L.L.C. | 4764f37b-c9e6-4ede-bcc2-8a03b7c521df | 2026-10-16 | Warnings, Adverse reactions | Name/manufacturer search |
| YERVOY | IPILIMUMAB | E.R. Squibb & Sons, L.L.C. | 2265ef30-253e-11df-8a39-0800200c9a66 | 2026-08-20 | Warnings, Adverse reactions | Name/manufacturer search |
| ELIQUIS | APIXABAN | E.R. Squibb & Sons, L.L.C. | e9481622-7cc6-418a-acb6-c5450daae9b0 | 2026-08-17 | Boxed warning, Warnings, Adverse reactions | Name/manufacturer search |
| ZENBEXUS | IBERDOMIDE | E.R. Squibb & Sons, L.L.C. | 3663d9cb-3f66-48ae-bf0a-6958bc0888de | 2026-08-13 | Boxed warning, Warnings, Adverse reactions | Name/manufacturer search |
| OPDIVO | NIVOLUMAB | E.R. Squibb & Sons, L.L.C. | f570b9c4-6846-4de2-abfa-4d0a4ae4e394 | 2026-08-12 | Warnings, Adverse reactions | Name/manufacturer search |
| SOTYKTU | DEUCRAVACITINIB | E.R. Squibb & Sons, L.L.C. | ff4d7258-5068-4cdf-9692-8cae04c3198e | 2026-06-30 | Warnings, Adverse reactions | Name/manufacturer search |
| OPDUALAG | NIVOLUMAB AND RELATLIMAB-RMBW | E.R. Squibb & Sons, L.L.C. | b22c9d83-3256-4e17-85f7-f331a504adc6 | 2026-06-08 | Warnings, Adverse reactions | Name/manufacturer search |
| OPDIVO QVANTIG | NIVOLUMAB AND HYALURONIDASE-NVHY | E.R. Squibb & Sons, L.L.C. | 7f8c38fa-42f4-4387-9e8c-7a1c66855d8b | 2026-05-12 | Warnings, Adverse reactions | Name/manufacturer search |
| Cobenfy | XANOMELINE AND TROSPIUM CHLORIDE | E.R. Squibb & Sons, L.L.C. | 8f0e73bf-6025-44f6-ab64-0983322de0df | 2026-01-16 | Warnings, Adverse reactions | Name/manufacturer search |
| AZACTAM | AZTREONAM | E.R. Squibb & Sons, L.L.C. | 9a105eaf-ee77-4016-beeb-d425a5565db2 | 2025-12-15 | Warnings, Adverse reactions | Name/manufacturer search |
| ORENCIA | ABATACEPT | E.R. Squibb & Sons, L.L.C. | 0836c6ac-ee37-5640-2fed-a3185a0b16eb | 2025-11-13 | Warnings, Adverse reactions | Name/manufacturer search |
| EVOTAZ | ATAZANAVIR AND COBICISTAT | E.R. Squibb & Sons, L.L.C. | 83db29d7-5d85-49d6-8cb6-740473365cf8 | 2025-05-12 | Warnings, Adverse reactions | Name/manufacturer search |
| REYATAZ | ATAZANAVIR | E.R. Squibb & Sons, L.L.C. | 165cff62-b284-4a27-a65d-9ec8a5bfcdd8 | 2024-12-05 | Warnings, Adverse reactions | Name/manufacturer search |
| KENALOG-10 | TRIAMCINOLONE ACETONIDE | E.R. Squibb & Sons, L.L.C. | ec04ecbb-2896-3feb-85fd-a64aba93b289 | 2024-08-26 | Warnings, Adverse reactions | Name/manufacturer search |
| KENALOG-40 | TRIAMCINOLONE ACETONIDE | E.R. Squibb & Sons, L.L.C. | cf970688-cd77-b95c-4bd9-c541590e9722 | 2024-08-20 | Warnings, Adverse reactions | Name/manufacturer search |
| Augtyro | REPOTRECTINIB | E.R. Squibb & Sons, L.L.C. | fb526827-40ba-4462-94cf-179ae3b0cb8a | 2024-06-13 | Warnings, Adverse reactions | Name/manufacturer search |
| EMPLICITI | ELOTUZUMAB | E.R. Squibb & Sons, L.L.C. | 80686b7e-f6f4-4154-b5c0-c846425e2d91 | 2022-03-22 | Warnings, Adverse reactions | Name/manufacturer search |
| NULOJIX | BELATACEPT | E.R. Squibb & Sons, L.L.C. | c16ac648-d5d2-9f7d-8637-e2328572754e | 2021-07-28 | Boxed warning, Warnings, Adverse reactions | Name/manufacturer search |
| BARACLUDE | ENTECAVIR | E.R. Squibb & Sons, L.L.C. | 046e61c9-9298-4b2e-b76e-b26b81fecd20 | 2019-11-06 | Boxed warning, Warnings, Adverse reactions | Name/manufacturer search |
| HALOG | HALCINONIDE | E.R. Squibb & Sons, L.L.C. | f6c7e87b-6629-4d68-ae46-add64ca9daab | 2006-07-06 | Adverse reactions | Name/manufacturer search |